LYEL
Lyell Immunopharma, Inc. Common Stock
$12.63
5.51%
+0.66
Notify me if price changes either direction
Buy LYEL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
294.7M
Enterprise value
74.1M
Trailing PE
-0.97797974586472
Forward PE
-14.250001
PEG Ratio
0.014082908340452
Enterprise to EBITDA
-0.421
Enterprise to revenue
2391.517
Price to book MRQ
1.0203733
Price to sales TTM
9009.969
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
31000
EBITDA
-176040000
Diluted EPS TTM
-13.62
Total Cash (MRQ)
254.0M
Current ratio (MRQ)
7.235
Operating Cash Flow (TTM)
-133796000
LYEL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
